BRIM Biotechnology, Inc.
Industry
- Biotechnology
- Pharmaceuticals
See more in Biomedtracker
Latest on BRIM Biotechnology, Inc.
Scrip
• By Dexter Jie Yan
Wrapping up a challenging 2023, Chinese pharma firms increasingly ventured into the US to initiate Phase III clinical trials to support future regulatory approvals from the US Food and Drug Administra
In Vivo
• By Maureen Riordan and Amanda Micklus
Financings Biopharma companies maintained the momentum set in Q1 financing activity by bringing in a total of $15.4 billion in the second quarter of 2015, slightly more than Q1's $15.1 billion. Most o
In Vivo
IN VITRO DIAGNOSTICS Mergers & Acquisitions Opko Health Inc. Bio-Reference Laboratories Inc. Opko Health Inc. acquired publicly traded Bio-Reference Laboratories Inc. (BRLI; clinical laborator